LSD: My Problem Child
The DOI matches its Crossref record.
Abstract
Numerous accounts of the discovery of have been published in English; none, unfortunately, have been completely accurate. Here, at last, the father of details the history of his problem child and his long and fruitful career as a research chemist. In a real sense, this book is the inside story of the birth of the Psychedelic Age, and it cannot be denied that we have here a highly candid and personal insight into one of the most important scientific discoveries of our time, the signiflcance of which has yet to dawn on mankind. Surpassing its historical value is the immense philosophical import of this work. Never before has a chemist, an expert in the most materialistic of the sciences, advanced a Weltanschauung of such a mystical and transcendental nature. LSD, psilocybin, and the other hallucinogens do indeed, as Albert Hofmann asserts, constitute in the edifice of materialistic rationality, cracks we would do well to explore and perhaps widen. As a writer, it gives me great satisfaction to know that by this book the American reader interested in hallucinogens will be introduced to the work of Rudolf Gelpke, Ernst Junger, and Walter Vogt, writers who are all but unknown here. With the notable exceptions of Huxley and Wasson, English and American writers on the hallucinogenic experience have been far less distinguished and eloquent than they. This translation has been carefully overseen by Albert Hofmann, which made my task both simpler and more enjoyable. I am beholden to R. Gordon Wasson for checking the chapters on LSD's Mexican relatives and on Ska Maria Pastora for accuracy and style. Two chapters of this book—How Originated and LSD Experience and Reality— were presented by Albert Hofmann as a paper before the international conference Hallucinogens, Shamanism and Modern Life in San Francisco on the afternoon of Saturday, September 30, 1978. As a part of the conference proceedings, the first chapter has been published in the Journal of Psychedelic Drugs, Vol. 11 (1-2), 1979. Jonathan Ott
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Carhart-Harris, R. L., Leech, R., Hellyer, P. J., Shanahan, M., Feilding, A., Tagliazucchi, E., Chialvo, D. R., & Nutt, D. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00020 · Cited by 1,252
Neural correlates of the LSD experience revealed by multimodal neuroimaging
Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L., Kaelen, M., Droog, W., Murphy, K., Tagliazucchi, E., Schenberg, E. E., Nest, T., Orban, C., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518377113 · Cited by 859
Serotonin and brain function: a tale of two receptors
Carhart-Harris, R., & Nutt, D. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117725915 · Cited by 739
The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future
Carhart-Harris, R. L., & Goodwin, G. M. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.84 · Cited by 706
Increased global functional connectivity correlates with LSD-induced ego dissolution
Tagliazucchi, E., Roseman, L., Kaelen, M., Orban, C., Muthukumaraswamy, S. D., Murphy, K., Laufs, H., Leech, R., McGonigle, J., Crossley, N., et al. (2016) · Current Biology · doi:10.1016/j.cub.2016.02.010 · Cited by 503
Structure and function of serotonin G protein-coupled receptors
McCorvy, J. D., & Roth, B. L. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.01.009 · Cited by 372
Johnson, M. W., Griffiths, R. R., Hendricks, P. S., & Henningfield, J. E. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.05.012 · Cited by 354
Psychiatry & the psychedelic drugs. Past, present & future
Rucker, J. J. H., Iliff, J., & Nutt, D. J. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.040 · Cited by 343
LSD enhances suggestibility in healthy volunteers
Carhart-Harris, R. L., Kaelen, M., Whalley, M. G., Bolstridge, M., Feilding, A., & Nutt, D. J. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3714-z · Cited by 320
“The remarkable psychological properties of LSD were first discovered by Albert Hofmann in 1943 (Hofmann 1980), and thereafter, LSD was investigated as a psychotomimetic (Fabing 1955) and tool to assist psychotherapy (Savage 1957) before regulatory restrictions in the mid-1960s that effectively suspended all of the rel…”
BackgroundThe paradoxical psychological effects of lysergic acid diethylamide LSD
Carhart-Harris, R. L., Kaelen, M., Bolstridge, M., Williams, T. M., Williams, L. T., Underwood, R., Feilding, A., & Nutt, D. J. (2016) · Psychological Medicine · doi:10.1017/s0033291715002901 · Cited by 293
Potential Therapeutic Effects of Psilocybin
Johnson, M. W., & Griffiths, R. R. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0542-y · Cited by 296
The hallucinogenic world of tryptamines: an updated review
Araújo, A. M., Carvalho, F., Bastos, M. D. L., Guedes de Pinho, P., & Carvalho, M. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1513-x · Cited by 292
Psilocybin – Summary of knowledge and new perspectives
Tylš, F., Páleníček, T., & Horáček, J. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.12.006 · Cited by 276
Clinical applications of hallucinogens: a review
Garcia-Romeu, A., Kersgaard, B., & Addy, P. H. (2016) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000084 · Cited by 201
Animal Models of Serotonergic Psychedelics
Hanks, J. B., & González-Maeso, J. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn300138m · Cited by 156
Psychedelic Drugs in Biomedicine
Kyzar, E. J., Nichols, C. D., Gainetdinov, R. R., Nichols, D. E., & Kalueff, A. V. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.08.003 · Cited by 155
Ethical and legal issues in psychedelic harm reduction and integration therapy
Pilecki, B., Luoma, J. B., Bathje, G. J., Rhea, J., & Narloch, V. F. (2021) · Harm Reduction Journal · doi:10.1186/s12954-021-00489-1 · Cited by 141
Karst, M., Halpern, J. H., Bernateck, M., & Passie, T. (2010) · Cephalalgia · doi:10.1177/0333102410363490 · Cited by 106
Values and Beliefs of Psychedelic Drug Users: A Cross-Cultural Study
Lerner, M., & Lyvers, M. (2006) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2006.10399838 · Cited by 98
Dakwar, E., Nunes, E. V., Hart, C. L., Hu, M. C., Foltin, R. W., & Levin, F. R. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.005 · Cited by 85
Do hallucinogens cause residual neuropsychological toxicity?
Halpern, J. H., & Pope, H. G. (1999) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00129-x · Cited by 82
Giluk (2009) · doi:10.1017/s003329172000389x · Cited by 68
The epistemic innocence of psychedelic states
Letheby, C. (2016) · Consciousness and Cognition · doi:10.1016/j.concog.2015.11.012 · Cited by 67
Elsey, J. W. B. (2017) · Drug Science Policy and Law · doi:10.1177/2050324517723232 · Cited by 57
Neurotoxicity and LSD treatment: a follow-up study of 151 patients in Denmark
Larsen, J. K. (2016) · History of Psychiatry · doi:10.1177/0957154x16629902 · Cited by 29
Metadata
- Authors
- Kohn, B., & Hofmann, A.
- Venue
- The Antioch Review
- Publisher
- JSTOR
- Published
- 1981
- Volume
- 39
- Issue
- 3
- Pages
- 389
- ISSN
- 0003-5769 (ISSN-L)
- OpenAlex
- W2326523421
- Cited by
- 144
- References
- 0
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.